Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-07

Clinical Trial Update: Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

View source ↗

Summary

Clinical trial update describing a follow-up magnetization transfer imaging study in relapsing-remitting multiple sclerosis patients treated with Tysabri (natal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tysabri (Natalizumab)

Snippet

Sponsor: University at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED